The significance of histological determination of HER-2 status in breast cancer

This publication has 30 references indexed in Scilit:

• The erbB/HER type 1 tyrosine kinase receptor family
  The Journal of Pathology, 1998
• Neu and its ligands: From an oncogene to neural factors
  BioEssays, 1993
• Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
  Cell, 1992
• Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis
  British Journal of Cancer, 1990
• Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
  Cell, 1988
• Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.
  Molecular and Cellular Biology, 1987
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985
• A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
  Proceedings of the National Academy of Sciences, 1985
• Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
  Cell, 1982